Transgene Biotek Q3 Results
- BSE: 526139
- NSE: -
- ISIN: INE773D01018
- Sector: Biotechnology & Drugs
BSE
3.08
0.00 (0.00%)
0.00 (0.00%)Volume24.30 K
Updated: Fri 10 Jul, 2026 | 15:29:41
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Transgene Biotek Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 0.15 | 0.16 | -12.55% | 0.18 | -19.43% |
| Depreciation/ Amortization | 0.05 | 0.02 | 0.00% | 0.02 | 114.66% |
| Operating Income | -0.10 | -0.10 | -19.26% | -0.13 | -13.25% |
| Net Income | -0.37 | -0.07 | -3.76% | -0.12 | 320.00% |
| Other Operating Expenses Total | 0.07 | 0.05 | -23.62% | 0.08 | -17.75% |
| Net Income Before Taxes | -0.37 | -0.07 | -3.76% | -0.12 | 320.00% |
| Total Revenue | 0.05 | 0.06 | 3.22% | 0.05 | -28.76% |
| Selling/ General/ Admin Expenses Total | 0.03 | 0.08 | 0.00% | 0.08 | -59.39% |
| Diluted Normalized EPS | -0.05 | -0.01 | 0.00% | -0.02 | 325.53% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.